SCHEMBL20343486

SCHEMBL20343486

O=C([C@H](O)c1ccccc1)N1C[C@H]2CCC[C@H]2C1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ JAK1 P23458 1/20 0.44
▸ USP9X Q93008 4/20 0.42
▸ CHRM3 P20309 3/20 0.41
▸ CES2 O00748 1/20 0.41
▸ CES1 P23141 1/20 0.41
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ CHRM5 P08912 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14359456 0.80 LMNA (0.47) LMNAMAPK1JAK1CHRM3CES2
SCHEMBL16365588 0.77 PLA2G1B (0.51) LMNAMAPK1JAK1
SCHEMBL7041710 0.77 ALDH1A1 (0.57) LMNAMAPK1CHRM3HSD17B10CHRM1
SCHEMBL27780237 0.76 DPP4 (0.46) LMNAMAPK1USP9XROCK2CYP3A4
SCHEMBL18171456 0.76 DPP4 (0.46) LMNAMAPK1USP9XROCK2CYP3A4
SCHEMBL7037673 0.76 CHRM1 (0.45) CHRM3CHRM1
SCHEMBL14359594 0.75 ACHE (0.50) MAPK1USP9XCHRM3ROCK2CYP3A4
SCHEMBL12744721 0.74 CHRNB2 (0.60) —
SCHEMBL24322583 0.70 SIGMAR1 (0.54) LMNAMAPK1ROCK2CYP3A4
SCHEMBL18390258 0.70 CHRM1 (0.63) CHRM3CYP2D6HSD17B10ROCK2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2796460-B1 PYRROLE SIX-MEMBERED HETEROARYL RING DERIVATIVE, PREPARATION METHOD THEREFOR, AND MEDICINAL USES THEREOF JIANGSU HENGRUI MEDICINE CO (CN) 2018-07-04 — — EP disclosed
Send feedback